Propofol Requirement for Induction of Unconsciousness Is Reduced in Patients with Parkinson’s Disease: A Case Control Study

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Medications</td><td align="center">Number of uses (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Levodopa/benserazide</td><td align="center">30 (96.8)</td></tr><tr><td align="left">Trihexyphenidyl</td><td align="center">10 (32.3)</td></tr><tr><td align="left">Levodopa/carbidopa</td><td align="center">6 (19.4)</td></tr><tr><td align="left">Amantadine</td><td align="center">6 (19.4)</td></tr><tr><td align="left">Pramipexole</td><td align="center">5 (16.1)</td></tr><tr><td align="left">Entacapone</td><td align="center">3 (9.7)</td></tr><tr><td align="left">Bromocriptine</td><td align="center">1 (3.2)</td></tr><tr><td align="left">Rasagiline</td><td align="center">1 (3.2)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

The anti-Parkinson medications taken by the patients with Parkinson’s disease.

BioMed Research International

tab2

Table 2

Table 2: Propofol Requirement for Induction of Unconsciousness Is Reduced in Patients with Parkinson’s Disease: A Case Control Study 